Works matching IS 13479032 AND DT 2025 AND VI 116 AND IP 1


Results: 27
    1
    2
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    FOXP3+/CD8+ ratio associated with aggressive behavior in RUNX3‐methylated diffuse esophagogastric junction tumor.

    Published in:
    Cancer Science, 2025, v. 116, n. 1, p. 178, doi. 10.1111/cas.16373
    By:
    • Maruyama, Suguru;
    • Imamura, Yu;
    • Toihata, Tasuku;
    • Haraguchi, Ikumi;
    • Takamatsu, Manabu;
    • Yamashita, Makiko;
    • Nakashima, Yuichiro;
    • Oki, Eiji;
    • Taguchi, Kenichi;
    • Yamamoto, Manabu;
    • Mine, Shinji;
    • Okamura, Akihiko;
    • Kanamori, Jun;
    • Nunobe, Souya;
    • Sano, Takeshi;
    • Kitano, Shigehisa;
    • Noda, Tetsuo;
    • Watanabe, Masayuki
    Publication type:
    Article
    17
    18
    19
    20
    21
    22

    Tasurgratinib in patients with cholangiocarcinoma or gastric cancer: Expansion part of the first‐in‐human phase I study.

    Published in:
    Cancer Science, 2025, v. 116, n. 1, p. 192, doi. 10.1111/cas.16354
    By:
    • Morizane, Chigusa;
    • Ueno, Makoto;
    • Ioka, Tatsuya;
    • Tajika, Masahiro;
    • Ikeda, Masafumi;
    • Yamaguchi, Kensei;
    • Hara, Hiroki;
    • Yabusaki, Hiroshi;
    • Miyamoto, Atsushi;
    • Iwasa, Satoru;
    • Muto, Manabu;
    • Takashima, Tsutomu;
    • Minashi, Keiko;
    • Komatsu, Yoshito;
    • Nishina, Tomohiro;
    • Nakajima, Takako Eguchi;
    • Takeno, Atsuchi;
    • Moriwaki, Toshikazu;
    • Furukawa, Masayuki;
    • Sahara, Takatoshi
    Publication type:
    Article
    23
    24
    25

    Issue Information.

    Published in:
    Cancer Science, 2025, v. 116, n. 1, p. 1, doi. 10.1111/cas.16215
    Publication type:
    Article
    26
    27